Skip to main content
. 2019 Jul 26;34(1):1368–1372. doi: 10.1080/14756366.2019.1643336

Table 2.

Antioxidant activity of 2–(3-oxo-2-phenoxypyrido[3,2-b]pyrazin-4(3H) -yl)acetic acid derivatives.

Inline graphic
Compd. Substituent
DPPH/sca%
R1 R2 100 μM 50 μM 10 μM
4a H H 6.9 ± 1.2
4b H 4-OCH3 18.9 ± 0.8
4c H 3,4-(OCH3)2 21.2 ± 1.5
4d H 3,5-(OCH3)2 25.9 ± 1.3
4e H 3,4,5-(OCH3)3 17.8 ± 0.9
4f H 4-OH 37.7 ± 1.0
4g H 3-OH, 4-OCH3 54.8 ± 1.6 21.5 ± 1.2
4h H 3,4-(OH)2 74.6 ± 1.4 44.1 ± 2.3
4i H 3-OH, 5-OCH3 78.4 ± 0.7 45.2 ± 1.8
4j H 3,5-(OH)2 95.0 ± 0.9 77.2 ± 1.5 45.3 ± 1.9
4k Cl 3,5-(OH)2 94.8 ± 1.1 76.4 ± 0.9 49.1 ± 2.4
4l Br 3,5-(OH)2 95.3 ± 1.2 80.6 ± 2.0 46.8 ± 1.5
4m H 3-OH, 4,5-(OCH3)2 56.9 ± 1.8 35.9 ± 1.1
4n H 3,5-(OH)2, 4-OCH3 65.7 ± 0.9 40.8 ± 1.6
4o H 3,4,5-(OH)3 88.5 ± 1.4 65.2 ± 1.9 23.4 ± 2.0
Trolox 96.7 ± 0.8 89.8 ± 1.0 85.9 ± 0.6